Molson Coors moving further out of beer category
Molson Coors will assume exclusive commercialization rights to the company's Fever-Tree lineup of tonics, ginger beers and ...
Molson earnings power ‘at odds’ with valuation, says Roth MKM
Roth MKM keeps a Buy rating on Molson Coors (TAP) with a $75 price target following the Q4 report. With investors down on the beer sector, ...
One of Colorado’s largest craft breweries is making major changes
As the craft beer industry continues to face trying economic times, one of Colorado’s largest independently owned breweries ...
Molson Coors beats quarterly estimates after beer demand rebounds in Americas
Molson Coors beat fourth-quarter sales and profit estimates on Thursday, helped by recovering demand for its beer brands ...
Molson Coors’ focus on pushing premium brands leads to upbeat profit outlook
The company also provided a full-year earnings outlook that guided for further growth, and was above Wall Street forecasts.